In turn, UCHL3 deubiquitinates RAD51 and promotes the binding between BRCA2 and RAD51, which play an important role in DNA damage repair and the resistance of cancer cells to radiation and chemotherapy (Davies et al., 2001; Luo et al., 2016; Zhao et al., 2017). This evidence concerns the gene UCHL3 and cancer.